Kathleen D. Scott sold $705K of ARS Pharmaceuticals (SPRY)

Executed May 20 2025, disclosed May 22 2025, 2 days later.

Value, as filed

$705K

50,000 sh × $14.10

Executed

May 20 2025

the trade date, as filed

Disclosed

May 22 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KS Kathleen D. Scott Chief Financial Officer profile →

Kathleen D. Scott (Chief Financial Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in SPRY. The largest single filing was $705K of SPRY (50,000 sh × $14.10, as filed), executed May 20 2025.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kathleen D. Scott in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $188K
12,500 sh × $15.00
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $200K
12,500 sh × $16.00
Exec Oct 16 2024
Filed Oct 17 2024 · 5:30 PM ET